Vext expands Ohio presence with new dispensary

Vext Science has announced that it has been granted a dual-use provisional license by the Ohio Division of Cannabis Control for a cannabis dispensary in Columbus, Ohio.

The Dispensary will be located on the west side of Columbus, near the I-270 and Roberts Road interchange, providing strong visibility from the city's primary beltway and convenient access within Ohio's largest cannabis market. The site sits adjacent to Hilliard and serves a growing residential area with limited nearby cannabis retail locations. The Dispensary will represent Vext's second location in Columbus.

The provisional license confirms the Dispensary complies with all applicable zoning and statutory setback requirements for both medical and adult-use retail sales. The Company has secured all required construction permits and executed a construction agreement for the build-out of a new standalone facility, including a drive-thru. Construction is expected to begin in March, with operations expected to commence in the fourth quarter of 2026, subject to regulatory approvals. Total capital costs are expected to be approximately $3.3 million, including land acquisition and construction.

Eric Offenberger, CEO of Vext commented, "Securing our seventh Ohio dispensary license is another important step in our disciplined retail expansion. Columbus is the state's largest cannabis market, and this high-visibility location near I-270 gives us access to a growing residential area with limited nearby competition. With five consolidated dispensaries currently operating in Ohio and our sixth location in Fairfield expected to open in Q2 of 2026, which given its location has the potential to become one of our strongest performing stores, we're building from a position of strength. Each new store extends the leverage of our vertically integrated platform and reinforces our margin and cash flow trajectory. With construction underway and our remaining Ohio projects advancing, we have a clear line of sight to the state's eight-store cap and remain committed to disciplined capital allocation and sustainable shareholder value creation."